More News

25 May 2021 Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
20 May 2021 BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
19 May 2021 Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
18 May 2021 BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases
14 May 2021 Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research
12 May 2021 Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
11 May 2021 Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
11 May 2021 Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders
05 May 2021 Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy
04 May 2021 UPPTHERA and ComInnex sign research collaboration for the development of novel Proteolysis-Targeting Chimera candidates
29 Apr 2021 Pfizer Acquires Amplyx Pharmaceuticals
26 Apr 2021 Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
22 Apr 2021 Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing
21 Apr 2021 Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review
20 Apr 2021 Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta Thalassemia
20 Apr 2021 Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer
15 Apr 2021 New protein degradation centre to lead drug discovery revolution
14 Apr 2021 BERG Announces Oncology Pipeline Advancements And Biomarker Developments For Clinical Decision Support In Breast Cancer At AACR
09 Apr 2021 Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
06 Apr 2021 Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics
05 Apr 2021 Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
02 Apr 2021 Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
02 Apr 2021 AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
02 Apr 2021 Eloxx Pharmaceuticals Acquires Zikani Therapeutics
30 Mar 2021 Leiden University Medical Center and Ixaka enter collaboration to strengthen knowledge of cell therapy candidate REX-001

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up